What does BIOCARTIS do?

BIOCARTIS is a research organisation in Mechelen. Public Limited, started on 2 July 2010, 1 establishment.

What is the address of BIOCARTIS?

The registered office of BIOCARTIS is located at Generaal De Wittelaan 11B, 2800 Mechelen.

Is BIOCARTIS still active?

Yes. According to the CBE (29 October 2026) BIOCARTIS is active, legal situation “Normale toestand”, started on 2 July 2010.

Is BIOCARTIS registered on Peppol?

Yes, BIOCARTIS is registered on the Peppol network with ID 0208:0827475227.

What is the enterprise number of BIOCARTIS?

The enterprise number of BIOCARTIS is BE0827475227.

When was BIOCARTIS founded?

BIOCARTIS was founded on 2 July 2010.

Who are the directors of BIOCARTIS?

According to the 2025 annual accounts, the directors of BIOCARTIS are: Randy Polonsky, Roger Moody.

Is BIOCARTIS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 July 2010; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did BIOCARTIS make in 2025?

BIOCARTIS recorded a loss after taxes of € 22,920,619 in financial year 2025.

What is the revenue of BIOCARTIS?

In its most recent annual accounts (2025), BIOCARTIS reported revenue of € 48,220,328.

How much does an employee at BIOCARTIS earn?

The average wage cost per full-time employee at BIOCARTIS was € 154,100 in 2025: staff costs of € 31.7 million for 205.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does BIOCARTIS have?

According to the 2025 annual accounts, BIOCARTIS has 205.6 full-time equivalents (FTE).

Does BIOCARTIS have a website?

Yes, BIOCARTIS has a website at biocartis.com.

BIOCARTIS (Public Limited) - Mechelen - BE0827475227

Dossier BIOCARTIS, printed on 29 October 2026 from databakkes.be/en/0827475227/biocartis. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Shrinking team NBB

FTE fell two years in a row, from 278.5 to 205.6.

Financials

Financial year 2025

BIOCARTIS from Mechelen, company number BE0827475227, closed financial year 2025 with a result of € -22.9 million after tax. For that financial year BIOCARTIS recorded revenue of € 48.2 million and equity of € 37.2 million. Compared with financial year 2024, the result moved from € -30.8 million to € -22.9 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 8, 2026.

What it is worth Healthy

€ 37.2 million

▼ 27% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -22.9 million

▲ 25 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 6.1 million

▼ 25% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -53.6 million.

People and assets in 2025

Full-time equivalents

205.6

▼ 22.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 27.3 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 31.7 million

▼ 4% vs 2024

€ 154,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5.4 million

▼ 14% vs 2024

Of which on lease € 5.4 million.

Debts at end 2025

Bank debt

€ 6.5 million

▲ 161% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 9.3 million

▼ 2% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 92 days on average.

Taxes and wages

€ 5.4 million

▼ 9% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 50,312,733 Revenue 2022: € 50,312,733 First fiscal year in the series	€ 51,725,302 Revenue 2023: € 51,725,302 ▲ 3% vs 2022 (€ 50,312,733) Favourable step	€ 46,156,202 Revenue 2024: € 46,156,202 ▼ 11% vs 2023 (€ 51,725,302) Unfavourable step	€ 48,220,328 Revenue 2025: € 48,220,328 ▲ 4% vs 2024 (€ 46,156,202) Favourable step	▲ 4%
Profit after taxes	€ -56,795,562 Profit after taxes 2022: € -56,795,562 First fiscal year in the series	€ -58,018,038 Profit after taxes 2023: € -58,018,038 ▼ € 1.2 million vs 2022 (€ -56,795,562) Unfavourable step	€ -30,758,759 Profit after taxes 2024: € -30,758,759 ▲ € 27.3 million vs 2023 (€ -58,018,038) Favourable step	€ -22,920,619 Profit after taxes 2025: € -22,920,619 ▲ € 7.8 million vs 2024 (€ -30,758,759) Favourable step	▲ € 7.8 million
Equity	€ 45,754,068 Equity 2022: € 45,754,068 First fiscal year in the series	€ -12,455,384 Equity 2023: € -12,455,384 ▼ € 58.2 million vs 2022 (€ 45,754,068) Unfavourable step	€ 51,029,523 Equity 2024: € 51,029,523 ▲ € 63.5 million vs 2023 (€ -12,455,384) Favourable step	€ 37,189,659 Equity 2025: € 37,189,659 ▼ 27% vs 2024 (€ 51,029,523) Unfavourable step	▼ 27%
Total debts	€ 50,146,888 Total debts 2022: € 50,146,888 First fiscal year in the series	€ 108,129,915 Total debts 2023: € 108,129,915 ▲ 116% vs 2022 (€ 50,146,888) Unfavourable step	€ 19,126,198 Total debts 2024: € 19,126,198 ▼ 82% vs 2023 (€ 108,129,915) Favourable step	€ 24,573,116 Total debts 2025: € 24,573,116 ▲ 28% vs 2024 (€ 19,126,198) Unfavourable step	▲ 28%
Cash	€ 12,981,572 Cash 2022: € 12,981,572 First fiscal year in the series	€ 27,022,494 Cash 2023: € 27,022,494 ▲ 108% vs 2022 (€ 12,981,572) Favourable step	€ 8,088,668 Cash 2024: € 8,088,668 ▼ 70% vs 2023 (€ 27,022,494) Unfavourable step	€ 6,053,156 Cash 2025: € 6,053,156 ▼ 25% vs 2024 (€ 8,088,668) Unfavourable step	▼ 25%
Retained profit	€ -56,795,562 Retained profit 2022: € -56,795,562 First fiscal year in the series	€ -58,018,038 Retained profit 2023: € -58,018,038 ▼ € 1.2 million vs 2022 (€ -56,795,562) Unfavourable step	€ -30,654,289 Retained profit 2024: € -30,654,289 ▲ € 27.4 million vs 2023 (€ -58,018,038) Favourable step	€ -53,574,908 Retained profit 2025: € -53,574,908 ▼ € 22.9 million vs 2024 (€ -30,654,289) Unfavourable step	▼ € 22.9 million
Bank debt	€ 18,079,911 Bank debt 2022: € 18,079,911 First fiscal year in the series	€ 11,034,899 Bank debt 2023: € 11,034,899 ▼ 39% vs 2022 (€ 18,079,911) Favourable step	€ 2,500,000 Bank debt 2024: € 2,500,000 ▼ 77% vs 2023 (€ 11,034,899) Favourable step	€ 6,525,000 Bank debt 2025: € 6,525,000 ▲ 161% vs 2024 (€ 2,500,000) Unfavourable step	▲ 161%
Balance sheet total	€ 95,900,956 Balance sheet total 2022: € 95,900,956 First fiscal year in the series	€ 95,674,531 Balance sheet total 2023: € 95,674,531 Unchanged (€ 95,900,956) Unchanged	€ 70,155,721 Balance sheet total 2024: € 70,155,721 ▼ 27% vs 2023 (€ 95,674,531) Unchanged	€ 61,762,775 Balance sheet total 2025: € 61,762,775 ▼ 12% vs 2024 (€ 70,155,721) Unchanged	▼ 12%
Employees (FTE)	312.5 Employees (FTE) 2022: 312.5 First fiscal year in the series	278.5 Employees (FTE) 2023: 278.5 ▼ 34 vs 2022 (312.5) Unchanged	227.8 Employees (FTE) 2024: 227.8 ▼ 50.7 vs 2023 (278.5) Unchanged	205.6 Employees (FTE) 2025: 205.6 ▼ 22.2 vs 2024 (227.8) Unchanged	▼ 22.2

Key figures of BIOCARTIS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BIOCARTIS?

What happened at BIOCARTIS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 Randy Polonsky stepped down as director. NBB
2028 Roger Moody stepped down as director. NBB
Jun 8, 2026 New annual accounts for financial year 2025: loss of € 22.9 million. Source: NBB ↗
2024 Randy Polonsky became a director. NBB
2023 Roger Moody became a director. NBB
Jul 2, 2010 New establishment in Mechelen. KBO
Jul 2, 2010 Start of the company according to the CBE. KBO

In short

From € 56.8 million loss in 2022 to € 22.9 million loss in 2025.

Paid € 228,088 in corporate taxes since 2022.

Pays suppliers within 92 days on average.

Original PDFs at the National Bank ↗

Management

Biocartis Holdings, Inc. 100%

BIOCARTIS

Biocartis S.r.l. 100%

The shares are held by Biocartis Holdings, Inc. (100%). It owns 100% of Biocartis S.r.l. itself.

Directors

According to the 2025 annual accounts

Randy Polonsky

Director

since 2024 · until 2030

Roger Moody

Director

since 2023 · until 2028

Shareholders

Biocartis Holdings, Inc.

100%

Participations

Biocartis S.r.l.

100%

Establishments

Establishment units

Physical locations of this company

Registered office

Generaal De Wittelaan 11B

2800 Mechelen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS biocartis.com

Canonical: https://www.biocartis.com/en

About

Technologies

Cloudflare CDNDrupalFont AwesomeGoogle FontsGoogle Tag ManagerSwiperjQuerylazysizes

Hosting & Email

Email provider

Microsoft 365

Hosting

CLOUDFLARENET - Cloudflare, Inc., US

DNS

Cloudflare DNS

Domain

biocartis.com

Registered

2007-05-11

Registrar

Network Solutions, LLC

Expires

2027-05-11

Website info

HTTPS Ja

Languages EN

Features

Blog Jobs Ads Contact page

Security

✓ HTTPS

✗ SPF

✓ DMARC

Network

✓ IPv6

✓ Load balancing

Details

Company number

0827.475.227

VAT number

BE 0827.475.227

Registered office

Generaal De Wittelaan 11B, 2800 Mechelen

Names & denominations

BIOCARTIS

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

2 July 2010

Peppol

Active · Active since 1 Jan 2001

Contact

biocartis.com

Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van medische laboratoria

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

BIOCARTIS

Warning lights

Financials

What happened to BIOCARTIS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Website

Technologies

Hosting & Email

Domain

Website info

Features

Security

Network

Details

Frequently asked questions